697 related articles for article (PubMed ID: 28579423)
1. Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.
Merhi B; Shireman T; Carpenter MA; Kusek JW; Jacques P; Pfeffer M; Rao M; Foster MC; Kim SJ; Pesavento TE; Smith SR; Kew CE; House AA; Gohh R; Weiner DE; Levey AS; Ix JH; Bostom A
Am J Kidney Dis; 2017 Sep; 70(3):377-385. PubMed ID: 28579423
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
Dad T; Tighiouart H; Joseph A; Bostom A; Carpenter M; Hunsicker L; Kusek JW; Pfeffer M; Levey AS; Weiner DE
Am J Kidney Dis; 2016 Aug; 68(2):277-286. PubMed ID: 26947217
[TBL] [Abstract][Full Text] [Related]
3. Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study.
Horace RW; Roberts M; Shireman TI; Merhi B; Jacques P; Bostom AG; Liu S; Eaton CB
Nephrol Dial Transplant; 2022 Jan; 37(2):382-389. PubMed ID: 33760035
[TBL] [Abstract][Full Text] [Related]
4. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
[TBL] [Abstract][Full Text] [Related]
5. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
[TBL] [Abstract][Full Text] [Related]
6. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
Weiner DE; Park M; Tighiouart H; Joseph AA; Carpenter MA; Goyal N; House AA; Hsu CY; Ix JH; Jacques PF; Kew CE; Kim SJ; Kusek JW; Pesavento TE; Pfeffer MA; Smith SR; Weir MR; Levey AS; Bostom AG
Am J Kidney Dis; 2019 Jan; 73(1):51-61. PubMed ID: 30037726
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
[TBL] [Abstract][Full Text] [Related]
8. Association of Serum Phosphorus Concentration with Mortality and Graft Failure among Kidney Transplant Recipients.
Jeon HJ; Kim YC; Park S; Kim CT; Ha J; Han DJ; Oh J; Lim CS; Jung IM; Ahn C; Kim YS; Lee JP; Kim YH
Clin J Am Soc Nephrol; 2017 Apr; 12(4):653-662. PubMed ID: 28159828
[TBL] [Abstract][Full Text] [Related]
9. Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure.
Bostom A; Steubl D; Garimella PS; Franceschini N; Roberts MB; Pasch A; Ix JH; Tuttle KR; Ivanova A; Shireman T; Kim SJ; Gohh R; Weiner DE; Levey AS; Hsu CY; Kusek JW; Eaton CB
Am J Nephrol; 2018; 47(4):275-282. PubMed ID: 29698955
[TBL] [Abstract][Full Text] [Related]
10. Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients.
Kang AW; Bostom AG; Kim H; Eaton CB; Gohh R; Kusek JW; Pfeffer MA; Risica PM; Garber CE
Nephrol Dial Transplant; 2020 Aug; 35(8):1436-1443. PubMed ID: 32437569
[TBL] [Abstract][Full Text] [Related]
11. Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.
Lim WH; Johnson DW; Hawley CM; Pascoe E; Wong G
Am J Kidney Dis; 2018 Jan; 71(1):102-111. PubMed ID: 29191625
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study.
Okumi M; Kakuta Y; Unagami K; Maenosono R; Miyake K; Iizuka J; Takagi T; Ishida H; Tanabe K;
Clin Exp Nephrol; 2018 Jun; 22(3):702-709. PubMed ID: 29159526
[TBL] [Abstract][Full Text] [Related]
13. Mortality after kidney transplant failure: the impact of non-immunologic factors.
Gill JS; Abichandani R; Kausz AT; Pereira BJ
Kidney Int; 2002 Nov; 62(5):1875-83. PubMed ID: 12371992
[TBL] [Abstract][Full Text] [Related]
14. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH
Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500
[TBL] [Abstract][Full Text] [Related]
15. Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial.
Ix JH; Katz R; Bansal N; Foster M; Weiner DE; Tracy R; Jotwani V; Hughes-Austin J; McKay D; Gabbai F; Hsu CY; Bostom A; Levey AS; Shlipak MG
Am J Kidney Dis; 2017 Mar; 69(3):410-419. PubMed ID: 28024930
[TBL] [Abstract][Full Text] [Related]
16. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
[TBL] [Abstract][Full Text] [Related]
17. Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients.
Patel SI; Chakkera HA; Wennberg PW; Liedl DA; Alrabadi F; Cha SS; Hooley DD; Amer H; Wadei HM; Shamoun FE
Vasc Med; 2017 Jun; 22(3):225-230. PubMed ID: 28466760
[TBL] [Abstract][Full Text] [Related]
18. Recipient Comorbidity and Survival Outcomes After Kidney Transplantation: A UK-wide Prospective Cohort Study.
Wu DA; Robb ML; Forsythe JLR; Bradley C; Cairns J; Draper H; Dudley C; Johnson RJ; Metcalfe W; Ravanan R; Roderick P; Tomson CRV; Watson CJE; Bradley JA; Oniscu GC
Transplantation; 2020 Jun; 104(6):1246-1255. PubMed ID: 31449188
[TBL] [Abstract][Full Text] [Related]
19. Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
Bostom AG; Carpenter MA; Hunsicker L; Jacques PF; Kusek JW; Levey AS; McKenney JL; Mercier RY; Pfeffer MA; Selhub J;
Am J Kidney Dis; 2009 Jan; 53(1):121-8. PubMed ID: 19022547
[TBL] [Abstract][Full Text] [Related]
20. Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.
Bansal N; Carpenter MA; Weiner DE; Levey AS; Pfeffer M; Kusek JW; Cai J; Hunsicker LG; Park M; Bennett M; Liu KD; Hsu CY
J Am Soc Nephrol; 2016 Jul; 27(7):2109-21. PubMed ID: 26538631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
